Hematology Protocols

Lymphoma

1. BrUOG NHL-227: Ofatumumab and Bortezomib in Patients with Low-Grade Non-Hodgkin Lymphoma that Relapse after Rituximab
   PI: Jorge Castillo, MD
   Sites: Rhode Island Hospital, The Miriam Hospital

2. FolBrite: A Multicenter, Open Label, Phase II Study of Bendamustine and Rituximab followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma  (D1015)
   PI: Eric Winer, MD
   Sites: Rhode Island Hospital, The Miriam Hospital